IP Library Granted Patent US 8,808,722
Granted Patent B2
US 8,808,722 · App. 13/807,035 · Granted Aug 19, 2014

Stable antiseptic compositions and methods

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,808,722
App. No.
13/807,035
Granted
Aug 19, 2014
Kind
B2
Abstract

Provided are methods of improving the stability of antiseptic compositions that include elemental iodine and certain hydroxycarboxylic acids, as well as stable, ready to use antiseptic compositions suitable for use in the nose and anterior nares.

Claims (38)

1. A tissue antiseptic composition comprising:

an antimicrobial agent which is an iodophor, wherein the iodophor is povidone-iodine, wherein the antimicrobial agent is present in a sufficient concentration to provide an available iodine concentration of 0.1 wt-% to 2 wt-%;

a hydroxycarboxylic acid present at a concentration of at least 2.5 wt-%;

an amine oxide; and

an iodide salt present in at least a concentration of 2.0 wt-% and at an amount of no greater than 10 wt-%,

wherein the composition is ready to use, and

wherein the composition exhibits a decrease in available iodine of no greater than 5% wt/wt when stored at 40° C. for about 6 months.

2. The tissue antiseptic composition of claim 1 , wherein the hydroxycarboxylic acid is present in an amount greater than 5 wt-%.

3. The tissue antiseptic composition of claim 1 , wherein the amine oxide is present in a concentration of 0.25 wt-% to 1.5 wt-%.

4. The tissue antiseptic composition of claim 1 , further comprising a monosaccharide, a sugar alcohol, or a combination thereof, wherein the monosaccharide, sugar alcohol, or combination thereof is present at a concentration of greater than 5% wt/wt.

5. The tissue antiseptic composition of claim 4 , wherein the composition comprises xylitol.

6. The tissue antiseptic composition of claim 1 , further comprising a surfactant; wherein the surfactant comprises an anionic surfactant, an amphoteric surfactant, a nonionic surfactant, a zwitterionic surfactant, or a combination thereof; wherein the anionic surfactant comprises a phosphate, phosphonate, sulfate, sulfonate, or a combination thereof.

7. The tissue antiseptic composition of claim 1 further comprising a vehicle, wherein the vehicle comprises water.

8. The tissue antiseptic composition of claim 7 wherein the vehicle further comprises a polyethylene glycol having a molecular weight of less than 1500.

9. The tissue antiseptic composition of claim 1 further comprising a thickener.

10. A tissue antiseptic composition comprising:

an antimicrobial agent which is an iodophor, wherein the iodophor is povidone-iodine, wherein the antimicrobial agent is present in a sufficient concentration to provide an available iodine concentration of 0.1 wt-% to 2 wt-%;

a monosaccharide, a sugar alcohol, or a combination thereof;

a surfactant;

water;

a thickener;

a hydroxycarboxylic acid present at a concentration of greater than 1.0 wt-%; an amine oxide; and

an iodide salt present at a concentration of greater than 2.0 wt-% to 10 wt-%,

wherein the composition is ready to use and wherein the composition is iodine stable, and

wherein the composition exhibits a decrease in available iodine of no greater than 5% wt/wt when stored at 40° C. for about 6 months.

11. The tissue antiseptic of claim 10 , wherein the surfactant is an anionic surfactant, a zwitterionic surfactant, or a combination thereof, wherein the anionic surfactant is a phosphate, phosphonate, sulfate, sulfonate, or a combination thereof.

12. The tissue antiseptic composition of claim 10 further comprising a polyethylene glycol having a molecular weight of less than 1500.

13. The tissue antiseptic composition of claim 10 , wherein the amine oxide is present at a concentration of 0.25 wt-% to 1.5 wt-%.

14. The tissue antiseptic composition of claim 10 comprising xylitol.

15. The tissue antiseptic composition of claim 10 , wherein the monosaccharide, sugar alcohol, or combination thereof is present at a concentration of greater than 5% wt/wt.

16. A method of decolonizing the nasal passages of a subject, the method comprising applying the composition of claim 1 to the nasal passages of the subject.

17. A method of disinfecting the tissue of a subject, the method comprising applying the composition of claim 1 to the tissue of the subject.

18. A method of stabilizing a tissue antiseptic composition comprising an iodophor and a hydroxycarboxylic acid, the method comprising:

providing a tissue antiseptic composition comprising; an antimicrobial agent which is an iodophor, wherein the iodophor is povidone-iodine, wherein the antimicrobial agent is present in a sufficient concentration to provide an available iodine concentration of 0.1 wt-% to 2 wt-%;

and a hydroxycarboxylic acid present at concentration of greater than 2.5 wt-%;

providing an amine oxide and an iodide salt;

mixing the amine oxide and the iodide salt with the tissue antiseptic composition to form a stabilized composition, wherein the amine oxide is present in the stabilized composition at a total concentration of 0.25 wt-% to 1.5 wt-% and the iodide salt is present in the stabilized composition at a total concentration of about 1.5 wt-% to 10 wt-%,

wherein the composition exhibits a decrease in available iodine of no greater than 5% wt/wt when stored at 40° C. for about 6 months.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2024
From: 3M INNOVATIVE PROPERTIES COMPANY
To: SOLVENTUM INTELLECTUAL PROPERTIES COMPANY
Reel/Frame 066430/0287 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 10, 2013
From: SCHOLZ, MATTHEW T.; LANGREBE, KEVIN D.; WLASCHIN, KATIE F.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 029601/0529 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 27, 2012
From: SCHOLZ, MATTHEW T.; LANDGREBE, KEVIN D.; WALSCHIN, KATIE F.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 029532/0103 →